Rise of Next-Gen Digital Health Companies in China's $900B Healthcare Ecosystem | Matrix Partners China Innovation Forum

On August 5, we will host a Chuangxianghui. Unlike previous editions, this Chuangxianghui will be held online.

At this Chuangxianghui event, we will center on the investment theme of “New Healthcare Services,” analyzing the new opportunities and trends that information technology has brought to various stakeholders across the healthcare industry chain under the catalyst of the pandemic, with a focus on “Structural Changes and the New Normal in New Healthcare Services in the Post-Pandemic Era.” Specifically, the discussion will be divided into the following four topics:

● In a healthcare industry chain valued at 6 trillion yuan, what are the emerging opportunities in new medical services? In the post-pandemic era, what new opportunities have arisen in the field of digital health?

● What are the characteristics of outstanding new medical service companies?

● How has the customer quadrant for new medical services shifted in recent years? How can one capture a larger share of the market?

● How to Seize the Digital Dividend in Pharmaceutical Marketing?

● Spurred by the pandemic, innovative pharmaceutical marketing firms find themselves at the center of attention: Are they a capital bubble or an inevitable trend?

● How does digital innovation empower pharmaceutical marketing and the primary healthcare market?

"Opportunities for Peak Shaving and Valley Filling in Healthcare Efficiency Through Digitalization"

● Racing against time to support Huoshenshan Hospital: What opportunities and challenges does digital innovation face in the midst of the epidemic?

● How will the trend of online healthcare change in the post-pandemic era?

● Can information technology enable more efficient allocation of medical resources between first- and second-tier cities and third- and fourth-tier cities, or even remote areas?

● In the era of explosive growth in domestic innovative drug R&D, how can pharmaceutical companies optimize their new services?

● From Software to Services, from Data to AI: How Can Information Technology Enhance Efficiency in the Healthcare Industry?

● How can new entrants break through the reputation and user trust established by incumbent pharmaceutical SaaS providers to rapidly penetrate the market?

This Chuangxianghui session will be held via Zoom. Please scan the QR code below. Upon approval of your registration, we will send you an SMS notification to join the group chat; please ensure your mobile number is entered correctly. Before the event begins, we will invite you to the group and share the meeting link and password.

At this Chuangxianghui event, we will center on new healthcare services and provide a comprehensive overview of investment opportunities, pandemic response practices, market demands, and entrepreneurial prospects from the perspectives of data application and digitalization. Every invited speaker is a firsthand witness at the forefront of the structural transformation in new healthcare services.

As a leading investment firm in China, Matrix Partners China (MPCi) is also one of the most active venture capital firms in the healthcare sector. Since 2014, MPCi has maintained an annual investment pace of 8–10 new healthcare companies, bringing its current portfolio to nearly 70 companies. By industry segment, “MPCi-affiliated healthcare companies” are distributed across four fields: innovative drugs, medical devices & diagnostics, digital health, and healthcare services. It is precisely due to our in-depth research, investment practice, and long-term support for growth in the healthcare track that we first proposed the investment theme of “New Healthcare Services,” gaining tangible insights into financing trends, frontier opportunities, business model iterations, and stage-specific challenges in corporate development.

Pharmaceutical companies are the primary clients for many startups in the emerging healthcare services sector. A decade into healthcare reform, changes in medical insurance policies have directly reshaped the landscape of pharmaceutical sales. The recent pandemic has further driven transformations in the sales organizational structures and strategies of pharmaceutical enterprises. While the shift from traditional medical representative models to digital marketing represents a significant trend and opportunity, various practical challenges and deficiencies persist in implementation. This Chuangxianghui session will address these issues from the perspectives of demand-side stakeholders and leading market players.

As China’s leading one-stop chronic disease management and smart healthcare platform, Zhiyun Health leveraged data and internet technologies to revolutionize medical efficiency during the recent outbreak, playing a critical role at a crucial juncture by promptly deploying its chronic disease management system at Huoshenshan Hospital as requested. Meanwhile, from late January through February, Zhiyun Health’s online consultation volume surged dramatically, reaching nearly 15 times the level recorded during the same period last year.

As a leading startup in the new healthcare services sector, Taimei Medical Technology positions itself as a digital operations platform for the life sciences industry, with business covering pharmaceutical R&D, pharmacovigilance, pharmaceutical marketing, and market access. According to the customer quadrant classification of new healthcare services, Taimei Medical Technology has expanded from initially serving pharmaceutical companies and CROs to clinical trial centers at medical institutions, taking a leading role in pioneering and iterating the business model of new healthcare services.

If you are interested in this Chuangxianghui event, we sincerely invite you to participate. We hope to invite: those who have already embarked on entrepreneurship in the field of new medical services; or those who are planning to start a business in this direction and are looking for opportunities.

This Chuangxianghui session will be conducted via Zoom. Please scan the QR code below. Upon approval of your registration, we will send you an SMS notification to join the group chat; please ensure that your mobile phone number is entered correctly. Before the event begins, we will invite you to the group chat and share the meeting link and password.

● Upon approval of your registration, we will send an SMS notification to invite you to the group. Please ensure that your mobile phone number is entered correctly.

● Guests who have joined the group, please update your group nickname to "Company + Name".

● This group is for notifications only. Please refrain from sending irrelevant messages before the conclusion of Chuangxianghui to avoid burying our meeting announcements; free discussion within the group is permitted after the meeting.

● Due to the potentially high number of applicants, we will conduct a certain level of screening. We sincerely apologize for any inconvenience this may cause and appreciate your understanding.